These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Radiofrequency ablation versus resection for technically resectable colorectal liver metastasis: a propensity score analysis. Wang LJ; Zhang ZY; Yan XL; Yang W; Yan K; Xing BC World J Surg Oncol; 2018 Oct; 16(1):207. PubMed ID: 30322402 [TBL] [Abstract][Full Text] [Related]
3. The prognosis of radiofrequency ablation versus hepatic resection for patients with colorectal liver metastases: A systematic review and meta-analysis based on 22 studies. Yang G; Wang G; Sun J; Xiong Y; Li W; Tang T; Li J Int J Surg; 2021 Mar; 87():105896. PubMed ID: 33588125 [TBL] [Abstract][Full Text] [Related]
4. Hepatectomy vs radiofrequency ablation for colorectal liver metastasis: a propensity score analysis. Lee H; Heo JS; Cho YB; Yun SH; Kim HC; Lee WY; Choi SH; Choi DW World J Gastroenterol; 2015 Mar; 21(11):3300-7. PubMed ID: 25805937 [TBL] [Abstract][Full Text] [Related]
5. Radiofrequency ablation vs. hepatic resection for resectable colorectal liver metastases. He N; Jin QN; Wang D; Yang YM; Liu YL; Wang GB; Tao KX J Huazhong Univ Sci Technolog Med Sci; 2016 Aug; 36(4):514-518. PubMed ID: 27465325 [TBL] [Abstract][Full Text] [Related]
6. Neoadjuvant Chemotherapy Followed by Radiofrequency Ablation May Be a New Treatment Modality for Colorectal Liver Metastasis: A Propensity Score Matching Comparative Study. Chen Y; Huang Y; Xu L; Wu J; Han F; Jiang H; Zheng P; Xu D; Zhang Y Cancers (Basel); 2022 Oct; 14(21):. PubMed ID: 36358739 [TBL] [Abstract][Full Text] [Related]
7. Neoadjuvant Chemotherapy Followed by Radiofrequency Ablation Prolongs Survival for Ablatable Colorectal Liver Metastasis: A Propensity Score Matching Comparative Study. Chen Y; Xu Y; Xu L; Han F; Huang Y; Jiang H; Wu J; Zhang Y Front Oncol; 2021; 11():758552. PubMed ID: 34745996 [TBL] [Abstract][Full Text] [Related]
8. Salvage RFA in patients with intrahepatic recurrence after major hepatic surgery for colorectal cancer liver metastases: mid-term outcome. Zimmermann M; Pedersoli F; Schulze-Hagen M; Lurje G; Isfort P; Kuhl C; Bruners P Eur Radiol; 2020 Feb; 30(2):1221-1227. PubMed ID: 31493210 [TBL] [Abstract][Full Text] [Related]
9. The role of radiofrequency ablation for treatment of metachronous isolated hepatic metastasis from colorectal cancer. Lee BC; Lee HG; Park IJ; Kim SY; Kim KH; Lee JH; Kim CW; Lee JL; Yoon YS; Lim SB; Yu CS; Kim JC Medicine (Baltimore); 2016 Sep; 95(39):e4999. PubMed ID: 27684857 [TBL] [Abstract][Full Text] [Related]
10. Potential for cure and predictors of long-term survival after radiofrequency ablation for colorectal liver metastases: A 20-years single-center experience. Weilert H; Sadeghi D; Lipp M; Oldhafer KJ; Donati M; Stang A Eur J Surg Oncol; 2022 Dec; 48(12):2487-2494. PubMed ID: 35718675 [TBL] [Abstract][Full Text] [Related]
11. Long-term outcomes of radiofrequency ablation combined with hepatectomy compared with hepatectomy alone for colorectal liver metastases. Imai K; Allard MA; Castro Benitez C; Vibert E; Sa Cunha A; Cherqui D; Castaing D; Baba H; Adam R Br J Surg; 2017 Apr; 104(5):570-579. PubMed ID: 28112813 [TBL] [Abstract][Full Text] [Related]
12. Survival Evidence of Local Control for Colorectal Cancer Liver Metastases by Hepatectomy and/or Radiofrequency Ablation. Canseco LM; Liu YW; Lu CC; Lee KC; Chen HH; Hu WH; Tsai KL; Yang YH; Wang CC; Hung CH Cancers (Basel); 2023 Sep; 15(18):. PubMed ID: 37760404 [TBL] [Abstract][Full Text] [Related]
13. Non-response to preoperative chemotherapy is a contraindication to hepatectomy plus radiofrequency ablation in patients with colorectal liver metastases. Mao R; Zhao JJ; Zhao H; Zhang YF; Bi XY; Li ZY; Zhou JG; Wu XL; Xiao C; Cai JQ Oncotarget; 2017 Sep; 8(43):75151-75161. PubMed ID: 29088853 [TBL] [Abstract][Full Text] [Related]
14. [Prognostic analysis of colorectal liver metastases treated by surgery combined with intraoperative radiofrequency ablation]. Mao R; Zhao JJ; Bi XY; Zhao H; Li ZY; Huang Z; Zhang YF; Chen X; Hu HJ; Wu XL; Hu XH; Cai JQ Zhonghua Wai Ke Za Zhi; 2017 Jul; 55(7):521-527. PubMed ID: 28655081 [No Abstract] [Full Text] [Related]
15. Comparison of the therapeutic efficacy between systemic chemotherapy with and without radiofrequency ablation for colorectal cancer liver metastases: A propensity score matching study. Hao W; Jun Z; Yan L; Zhong-Yi Z; Bin-Bin J; Gui-Ju L; Wei Y; Lin S; Kun Y Br J Radiol; 2023 Aug; 96(1148):20221195. PubMed ID: 37191629 [TBL] [Abstract][Full Text] [Related]
16. Radiofrequency ablation versus resection for resectable colorectal liver metastases: time for a randomized trial? An update. Mulier S; Ruers T; Jamart J; Michel L; Marchal G; Ni Y Dig Surg; 2008; 25(6):445-60. PubMed ID: 19212117 [TBL] [Abstract][Full Text] [Related]
17. [Long-term outcomes of patients undergoing hepatectomy for bilateral multiple colorectal liver metastases-a propensity score matching analysis]. Bao Q; Wang K; Wang HW; Jin KM; Xing BC Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Oct; 23(10):976-983. PubMed ID: 33053993 [No Abstract] [Full Text] [Related]
18. Radiofrequency ablation for metachronous liver metastasis from colorectal cancer after curative surgery. Park IJ; Kim HC; Yu CS; Kim PN; Won HJ; Kim JC Ann Surg Oncol; 2008 Jan; 15(1):227-32. PubMed ID: 17882491 [TBL] [Abstract][Full Text] [Related]
19. Short- and long-term outcomes of hepatectomy combined with intraoperative radiofrequency ablation for patients with multiple primarily unresectable colorectal liver metastases: a propensity matching analysis. Liu M; Wang K; Wang Y; Bao Q; Wang H; Jin K; Liu W; Xing B HPB (Oxford); 2021 Oct; 23(10):1586-1594. PubMed ID: 33934959 [TBL] [Abstract][Full Text] [Related]
20. Outcome after laparoscopic radiofrequency ablation of technically resectable colorectal liver metastases. Hammill CW; Billingsley KG; Cassera MA; Wolf RF; Ujiki MB; Hansen PD Ann Surg Oncol; 2011 Jul; 18(7):1947-54. PubMed ID: 21399885 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]